Immunitybio alert: bragar eagel & squire, p.c. is investigating immunitybio, inc. on behalf of long-term stockholders and encourages investors to contact the firm

New york , feb. 27, 2025 (globe newswire) -- bragar eagel & squire, p.c., a nationally recognized shareholder rights law firm, is investigating potential claims against immunitybio, inc. (nasdaq: ibrx) on behalf of long-term stockholders following a class action complaint that was filed against immunitybio on august 29, 2023 with a class period from may 23, 2022 to may 10, 2023. our investigation concerns whether the board of directors of immunitybio have breached their fiduciary duties to the company.
IBRX Ratings Summary
IBRX Quant Ranking